We’re continuing here our series on Wastewater 101 topics, with a deep dive into the Membrane Bioreactor technology (MBR). This summary article is intensively sourced in the conversation that we had on the podcast with Dr. Graeme Pearce, Principal at Membrane Consultancy Associates, and an expert in membrane treatment for 40 years.
This is part of the special series of “Water & Wastewater 101” episodes we run on the (don’t) Waste Water podcast!
The rise of Membrane Treatments
Although membranes had been around since 1748, and the discovery of Osmosis by Jean-Antoine Nollet, their large-scale adoption in the water industry has taken quite a while. The reason is shared by Graeme Pearce in his podcast interview:
Getting the pore size under control would take membrane manufacturers a mere two centuries. The first breakthrough was achieved in Germany in the 1920’s, when Nobel-Prize winner Richard Zsigmondy teamed up with Sartorius AG to produce commercial-scale Ultrafiltration membranes.
Crossflow filtration and polysulfone membranes would then appear in the 1960s. And specialized companies in the US were addressing niche applications. Nothing that would significantly move the needle!
But change was around the corner: petrochemical companies started looking into separation research, quickly identifying membranes as a promising horse to bet on. This happened in the 1980’s, and this is also when Graeme Pearce joined BP.
From BP Research to Standalone Membrane Company
At the times, BP became excited about separation research, to the point that by 1988, 80 people were working full time on R&D in this field.
This of course had a cost, so that BP started seeking payback, thus founding BP Ventures Company. That wouldn’t last: BP quickly seeked to sell it. And Graeme, at the times, Process Engineering Manager of the company, teamed up with the other executives to do a management buy-out. This lead to the foundation of Kalsep!
During the BP times, membranes had been investigated as an alternative to distillation. But the newly inducted start-up aimed at a pivot, focusing instead on the water market.
A membrane adoption curve suddenly sped up
In doing so, they escaped a conservative market, not really ready to adopt membranes to focus instead on… another conservative market, not much more ready to do so.
But change was around the corner. In the UK and in the US, outbreaks of cryptosporidium emerged as a new threat to water treatment. This parasite, about four microns in diameter, was indeed small enough to get through conventional treatment. Yet membranes were a complete barrier!
As Graeme recalls, legislation created a strong driver for membranes, by enforcing complete removal of that microorganism.
Soon, ultrafiltration became almost mandatory in the 5-10% of the water sources exposed to cryptosporidium in the US and the UK.
In continental Europe, the driver was a bit different, the focus being less on this parasite. Instead, countries like Netherlands or France wanted to reduce their chlorine dependency. Hence they saw membranes as a universal barrier to viruses and microorganisms.
Fast-growing membrane companies
With regulations enforcing the use of membranes in a significant portion of the world, Kalsep experienced a significant growth.
A full sector of the drinking water industry was almost built from scratch in under a decade. But as you might expect from an article calling “Membrane Bioreactor” from its title, it would not stay parked there!
Membranes had a lot to offer in other parts of the water sector, starting with wastewater treatment.
But as with all rapid growths, some childhood diseases also appeared. Companies were too aggressive with their designs, or products simply did not withstand the test of times. This lead Graeme to enter the consultancy world, to have the opportunity to be more agnostic and objective.
Which makes him even more of the coolest guide there is, to discuss objectively Membrane Bioreactors.
What is a Membrane Bioreactor (MBR)?
First things first, let’s define it. A Membrane Bioreactor (MBR) is the combination of a biological reaction stage and a membrane barrier.
But to better understand where it comes from, and what it can achieve, let’s go back to the roots of MBRs.
But by then, nobody really paid attention. And when they got more than crickets, the reaction was along the lines of “too expensive” or “never going to work”. (quite a lesson of innovation, right?)
The two drivers that helped Membrane Bioreactors (MBRs) to become a thing
So while Zenon was professing in the desert, two drivers slightly helped.
The first was a regulation reinforcement on wastewater discharge to rivers.
Indeed, the EU directive, first adopted in 1991 then augmented in 1998 wasn’t expressively calling for treatment levels only achievable with membranes. So it was sure less of a driver than the cryptosporidium one on the clean side. But still, it pushed companies to improve their wastewater treatment, which gave Zenon a lever for conviction.
The next driver came quite later but is a bit stronger. It’s the driver for reuse.
This time, membranes are almost a go-to to achieve the desired treatment levels. But in many countries, those regulations are still in their baby pants, and regulators tigers without teeth.
So Membrane Bioreactors had to be enforced differently, without the strong supporting hand of regulations.
Is a Membrane Bioreactor (MBR) simply better?
Why would a technology still get adopted, if it’s at first more expensive, and not made mandatory by legislation?
Well, let’s check the existing standard when Membrane Bioreactors first appeared. Your Wastewater Treatment Plant relies on a biological treatment within conventional activated sludge tanks. Micro-organisms break down the nutrients and it creates sludge. This sludge then settles in clarifiers, and you might sometimes drive all of this on sand filters to remove some of the remaining solids.
That’s the status quo, and it’s around since the beginning of the XXth century.
So, membrane bioreactors turn wastewater treatment into a small, compact and efficient process. Which is awesome, but also makes hardware such as concrete tanks redundant.
That made adoption difficult in Europe, because the radical disruption did not allow for a smooth reuse of legacy plants. But in other places, that would just fit perfectly!
China hosts 65% of the World’s installed Membrane Bioreactor (MBR) base
Take a country like China. They have limited to no existing infrastructure, yet they need to treat wastewater to protect the environment but above all their industry.
So does that mean that MBRs are superior in any aspects to conventional activated sludge? Well it still depends on your intended treatment level.
If you’re like China, and aiming at “Class 1A” waters, then probably yes. But if quality of the discharges water can be a bit lower, then conventional treatments are still less expensive.
The footprint element is equally important: in a country as crowded as China, with ever growing cities, you cannot afford large Victorian Water Works like you would see in London.
Membrane bioreactors (MBRs) as an industrial wastewater treatment
Now, if we stay on that footprint element, there is another place beside Chinese Cities where it is a killer argument: in industries.
Footprint saving is a strong driver for the booming adoption of MBR in industrial wastewater treatment, yet not the only one. Another important aspect is the return on investment (ROI).
Conventional treatments might be a bit cheaper in operation than an MBR, but they imply heavy civil works investment. Altogether, it builds for a close call when it comes to total costs of ownership in the municipal world, where you’re calculating with 20-30 years investment.
But in the industrial world, amortizing times are much shorter, hence the Membrane Bioreactor solution even more appealing.
Last but not least, Membrane Bioreactors are very forgiving when it comes to changes in the water quality.
That degree of tolerance actually comes from the membrane. But talking of membranes, what do they look like?
Anatomy of a membrane bioreactor (MBR)
Depending on the manufacturer (as for the MABRs), membranes used in MBRs might be flat sheet or hollow fiber. And their primary material historically was PVDF, but could as well become ceramics.
Polymeric vs Ceramic Membranes
But recent developments have placed ceramic membranes as an interesting alternative. Traction is still in the early stages, but ceramics allow for a very aggressive sort of mechanical and chemical cleaning.
Historically in the 90s, cost reasons have made polymeric membranes a go-to. But ceramic membranes are made of very inexpensive materials, what adds a lot of costs is the manufacturing process.
So, if you can reduce those costs – and the labor input, what stays is the capital investment for equipment. And here again, higher produced amounts means economies of scale. Which comes on top of the performance advantage they offer, that pays them back on the long run.
On the other hand, ceramics are rigid, which slightly changes the way you operate your membrane bioreactor.
Now, you could replace this cleaning by an explosive backwash, which has the big advantage of being much more effective than the “aeration cleaning”.
Flat Sheet vs Hollow Fiber Membranes
Regarding shape and geometry, there is an overall leveling and smoothing of the argumentation. This is very true in the general membrane market, a bit less in Membrane Bioreactors.
in MBRs, the picture is still slightly different, with companies advocating whether for the one or for the other shape.
To distinguish between hollow fiber and flat sheet in membrane bioreactor technologies, there are some universal rules, as Graeme Pierce recalls:
Then, as often in wastewater treatment, it’s a case by case, one by one story.
Membrane Bioreactors (MBRs) as a plant upgrade?
We’ve seen that MBRs are an awesome go-to when there’s no infrastructure existing, and even more if space is limited and the quality of the effluent strictly regulated.
But be it in Europe, parts of the US or in large chunks of Asia, like Japan or South Korea, many plants will be reaching their age limit in the next decade. Often, they now face higher incoming pollution, so that they don’t only need to be refurbished, but also upgraded.
This is another sweet spot for Membrane Bioreactors.
Now, if it has many perks, especially on footprint and process intensification, it is still not a silver bullet either. Indeed, it still remains a bit tricky, and expensive.
But by achieving this kind of upgrade, you turn a secondary treatment (conventional activated sludge) into a “tertiary plus” if not quaternary treatment.
Reuse, is again a driver for Membrane Bioreactors MBRs
Now think of it. You’re like 50% of the US Wastewater treatment plants (representing about one third of the sewage flow), and you solely rely on primary and secondary treatment.
If you were to upgrade your plant and add a conventional tertiary treatment, such as a sand filter, you would sure improve the water outlet quality. But still not to reuse levels!
So now, if you consider instead upgrading to an MBR, you reach these reuse levels, be it for non-potable reuse, indirect potable reuse (such as aquifer recharge) or full-blown closed loops (through an additional polishing).
So again, as we’ve seen it previously, wastewater reuse is a driver for Membrane Bioreactors.
When it comes to Membrane Bioreactors (MBRs), size matters!
We’ve seen the larger scale chunk of the market. But that’s barely a majority in flows: the distributed side, so the aggregation of smaller treatment units is the booming sector in the water industry for a reason.
And this distinction in size actually matters. Because on the largest scale, conventional treatments are hard to beat in cost-benefit ratio. But that changes with scale:
there are two rules to get, to understand this:
- Conventional Activated Sludge are living organisms with little appeal for high variations in flows and loads. This makes them hardly operable at small scale. Meanwhile, sturdy MBRs are much more flexible, thanks to the membrane element making it a good fit for low flows.
- MBRs are, even in their most advanced form, a series of standard building blocks. So scaling up Membrane Bioreactors equals to multiplying the number of modules, with thus limited economies of scale. On the other end of the spectrum, conventional treatments are always cheaper per m3 the larger they get.
A Membrane Bioreactor (MBR) is not a silver bullet (spoiler: there is no silver bullet in wastewater treatment!)
We’ve seen right now, that for very large plants, Membrane Bioreactors would probably be beaten by conventional treatments, because of the economies of scale.
We previously also addressed the case where, regulation wouldn’t anyways enforce the quality that an MBR would deliver, thus making it an overkill.
There’s a third case, where Membrane Bioreactors meet their limits:
Think here of filament bacteria, and especially oily and greasy contaminants. Even worse if those are synthetic. But in all honesty, conventional treatments would struggle here as well!
Conclusion on Membrane Bioreactors (MBRs)
You should by now better grasp the Membrane Bioreactor technology! If you want to even dig further, you shall listen to Graeme Pearce’s full interview.
Wastewater reuse is going to be a major challenge of tomorrow (remember, we’ve already addressed it here!). And obviously it’s embedded in this podcast’s name: DON’T WASTE WATER!
Membrane Bioreactors are one of the most suited tools in the toolbox of modern wastewater treatment companies and operators, and after this deep dive, I’m pretty sure we all better know why.
Did we leave questions open? Please don’t hesitate to reach out!